Japanese Japanese

Regular Meeting

Access to the questionnaire result is limited to only those members who have paid their various membership fees correctly. Please be aware that access will be restricted for those members who have ID and password but not made their payment. For those wishing to apply for membership, please register here.

KBCCC the 7th Regular Meeting (01/25/2010 Updated)

This event is finished.

Date and Time:

23rd January (Sat), 2010.  Registration will be available at 15:00.

Venue:

The Westin Miyako Kyoto, The West 4F, Room "Mizuho-no-ma"

Programme:

15:15 - 15:30:
Presentation by Novartis Pharma K.K.  about  products' information

15:30 - 18:30:

1.  Opening address
    Dr. Ryuji Okamura, Surgery, Yamato Takada Municipal Hospital

2.  Report of the 7th Questionnaire Results:
    Dr. Tomoharu Sugie, Breast Surgery, Kyoto University Hospital

3.  Report of  the present situation:
    Chair:     Dr. Tomoharu Sugie, Breast Surgery, Kyoto University Hospital

(1) Dr. Yukiko Matsumura, Dr. Shotaro Kanao, Radiotherapy, Kyoto University Hospital
(2) Dr. Mariko Gotou, Kyoto Breast Centre Sawai Clinic
(3) Dr. Masae Torii, Kitano Hospital

4.  Mini Lecture:
"Minimum Requirements for Breast MRI"
Lecturer:    Dr. Mitsuhiro Tozaki, Breast Centre, Kameda Medical Centre
Chair:        Dr. Shotaro Kanao, Diagnostic Radiology, Kyoto University Hospital

5.  Discussion:
 "Clinical Application from Diagnosis by Breast MRI "
-Partnership between Diagnostic Radiologists and Surgical Oncologists-
Moderators: Dr. Masakazu Toi, Breast Surgery, Kyoto University Hospital
                  Dr. Shotaro Kanao, Diagnostic Radiology, Kyoto University Hospital

6.  Note:
"Study of Herceptin Cohort"
        Dr. Hiroyasu Yamashiro, Breast Surgery, Kyoto University Hospital

7.  Closing address:

Participation Fees: JPY3,000-
After the meeting, a reception for information exchange will be scheduled.

Co-organisers:
Kyoto Breast Cancer Consensus Conference
Ministry of Education, Culture, Sports, Science and Technology
"Medical Professionals Training Plan for Prevention and Remedy against Cancer"
Novartis Pharma K.K.

 

Questionnaire Results  click here (members only)